134 related articles for article (PubMed ID: 25460147)
21. Effects of medium-chain fatty acids on intracellular calcium levels and the cytoskeleton in human intestinal (Caco-2) cell monolayers.
Kimura Y; Hosoda Y; Yamaguchi M; Nagano H; Shima M; Adachi S; Matsuno R
Biosci Biotechnol Biochem; 2001 Apr; 65(4):743-51. PubMed ID: 11388448
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of absorption enhancement for a potent cyclopeptidic alpha(nu)beta(3)-antagonist in a human intestinal cell line (Caco-2).
Kamm W; Jonczyk A; Jung T; Luckenbach G; Raddatz P; Kissel T
Eur J Pharm Sci; 2000 May; 10(3):205-14. PubMed ID: 10767598
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
24. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers.
Liu DZ; Morris-Natschke SL; Kucera LS; Ishaq KS; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1169-74. PubMed ID: 10564066
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
27. Aggregation Behavior of Medium Chain Fatty Acids Studied by Coarse-Grained Molecular Dynamics Simulation.
Hossain MS; Berg S; Bergström CAS; Larsson P
AAPS PharmSciTech; 2019 Jan; 20(2):61. PubMed ID: 30627943
[TBL] [Abstract][Full Text] [Related]
28. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays.
Brayden DJ; Stuettgen V
Eur J Pharm Sci; 2021 Apr; 159():105737. PubMed ID: 33524502
[TBL] [Abstract][Full Text] [Related]
29. Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models.
Aguirre TA; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):856-65. PubMed ID: 25445305
[TBL] [Abstract][Full Text] [Related]
30. Interaction with Mixed Micelles in the Intestine Attenuates the Permeation Enhancing Potential of Alkyl-Maltosides.
Gradauer K; Nishiumi A; Unrinin K; Higashino H; Kataoka M; Pedersen BL; Buckley ST; Yamashita S
Mol Pharm; 2015 Jul; 12(7):2245-53. PubMed ID: 25874852
[TBL] [Abstract][Full Text] [Related]
31. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
[TBL] [Abstract][Full Text] [Related]
32. Correlation between epithelial toxicity and surfactant structure as derived from the effects of polyethyleneoxide surfactants on caco-2 cell monolayers and pig nasal mucosa.
Ekelund K; Osth K; Påhlstorp C; Björk E; Ulvenlund S; Johansson F
J Pharm Sci; 2005 Apr; 94(4):730-44. PubMed ID: 15682384
[TBL] [Abstract][Full Text] [Related]
33. In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
Drug Dev Ind Pharm; 2008 Mar; 34(3):279-88. PubMed ID: 18363143
[TBL] [Abstract][Full Text] [Related]
34. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
35. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
[TBL] [Abstract][Full Text] [Related]
37. The effect of phospholipids and fatty acids on tight-junction permeability and bacterial translocation.
Sawai T; Drongowski RA; Lampman RW; Coran AG; Harmon CM
Pediatr Surg Int; 2001 May; 17(4):269-74. PubMed ID: 11409160
[TBL] [Abstract][Full Text] [Related]
38. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics.
Perinelli DR; Vllasaliu D; Bonacucina G; Come B; Pucciarelli S; Ricciutelli M; Cespi M; Itri R; Spinozzi F; Palmieri GF; Casettari L
Eur J Pharm Biopharm; 2017 Oct; 119():419-425. PubMed ID: 28743594
[TBL] [Abstract][Full Text] [Related]
39. The pH of Piperazine Derivative Solutions Predicts Their Utility as Transepithelial Permeation Enhancers.
Lamson NG; Cusimano G; Suri K; Zhang A; Whitehead KA
Mol Pharm; 2016 Feb; 13(2):578-85. PubMed ID: 26730955
[TBL] [Abstract][Full Text] [Related]
40. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery.
Cano-Cebrián MJ; Zornoza T; Granero L; Polache A
Curr Drug Deliv; 2005 Jan; 2(1):9-22. PubMed ID: 16305404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
